PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jgfmLink to Publisher's site
 
J Gen Fam Med. 2017 April; 18(2): 52–55.
Published online 2017 April 4. doi:  10.1002/jgf2.39
PMCID: PMC5689387

Travel medicine: Part 1–The basics

Kazuhiro Kamata, MD, 1 Richard B Birrer, MD, MPH, FACP, FACEP, FAGS, FACPE, 2 and Yasuharu Tokuda, MD, MPH, PhD, FACPcorresponding author 3

Abstract

International travels for tourism and business purposes continue to increase annually, while the global terrorism and the risk of lethal viral infections are currently real concerns. It is important that primary care physicians assess travel risk and adequately prepare the prospective traveler for trips. Appropriate vaccines should be administered and an emergency self‐kit recommended. Patient should be educated about safe travel habits and a posttravel follow‐up process established. Further, traveling healthcare professionals may be called upon to assist an ill patient at any time during their journey. In these 2‐part special articles, we provide a practical brief summary of up‐to‐date travel medicine basics for primary care physicians.

Keywords: infectious disease, international traveler, travel medication, tropical infection, vaccination

1. Travelers’ Trend

The number of international travelers annually is continuously growing, although there was a dip in travelers, following the World Trade Center Terrorism Attack at New York City on 9/11/2001. Most international travelers go to developed countries, particularly Europe, but a substantial number of expatriates and adventure travelers go to developing countries around the world. It is expected that both trends will continue to increase over the next decade. Primary care physician is likely to be consulted by prospective travelers with respect to required vaccines, health hazards in host countries and adequate preparation to avoid illness.1, 2

2. Preparations

All prospective travelers should have their health history reviewed for the possible health risks of the planned itinerary. Information such as the dates, duration, routes, style of travel (eg, budget vs luxury), accommodations, and activities (eg, business vs leisure) should be collected.3

It is important to let the prospective traveler understand that he/she has a 15% chance of becoming sick during their trip in average,4 but the chance of a serious illness or death is very small (Table 1). A study about the incidence of health problems during a stay in developing countries 2008 indicates that travelers’ diarrhea has the greatest incidence (20%‐60% of all travelers).5

Table 1

Estimated disease frequency of 100 000 travelers to a developing country for 1 mo

Additional risks include accidental injury, environmental hazards (eg, hypo‐or hyperthermia), crime and assault, underlying medical and psychiatric problems, animal bites, stings and envenomations, and altitude‐related illness.6 The greatest cause for mortality among travelers is cardiovascular disease. The highest external cause for mortality among travelers is motor vehicle accident, followed by drowning.

On the other hand, infectious disease causes only 1% death among travelers.6 Despite the low mortality, the incidence of infectious disease is very high among travelers, and common infectious diseases with risks to international travelers are listed in Table 2. Enterotoxigenic E. coli (ETEC) is the leading pathogen in travelers’ diarrhea.5 Common health problems among travelers include circadian desynchronosis (jet lag), sunburn, dehydration, and water‐related problems (eg, exposure to infectious agents, near‐drowning, boating, and diving accidents).

Table 2

Common infectious diseases with risks to international travelers

A focused past medical history and review of systems should be performed, emphasizing age specific issues, underlying illness, and immunosuppression (eg, splenectomy, certain medications), allergies, and vaccinations.7 Individuals with inflammatory bowel disease do not have increased bouts of traveler's diarrhea compared to normal travelers, but when it occurs it is often severe. Travelers with congestive heart failure or chronic obstructive pulmonary disease may decompensate at altitude including a long haul flight. During pregnancy, or its possibility, risk‐taking behaviors (eg, off‐road trekking and adventure.) should be avoided.8

The physical examination should be updated particularly whether the patient has a chronic illness such as diabetes or cardiovascular pathology. Medications should be reviewed and adequate prescriptions provided for a secondary travel supply. Ideally, a summary of the patient's health data should accompany her/him in case the patient becomes ill while traveling. Not only the destination but also mode of travel should be considered. Open jaw stopovers may expose the unwary traveler to an infectious or traumatic event since the patient may have to get commercial sexual contacts or ride a reckless vehicle unexpectedly in cities the patient does not prospectively collect information on.

3. Patient Education

Sufficient time should be allowed for tailored patient education. The session should summarize the visit with a clear discussion of traveler's fitness for travel, important precautions, health insurance coverage for hospitalization, and evacuation, the availability of healthcare in the planned destination and the importance of a follow‐up visit, particularly for long‐term stays, such as expatriates working in developing countries or adventure travelers upon return to home.

Personal hygiene, especially hand washing, should be stressed. Food and water precautions include the use of bottled water, eating food that is cooked hot, and cold food when it is cold. All fresh fruit should be eaten after peeling. Unpasteurized dairy products should be avoided unless it was prepared from bottled water.

Vector precautions include covering exposed skin (ie, blousing) using insect repellent containing DEET (N, N‐diethyl‐meta‐toluamide) 25%‐50%, treating outer clothing with permethrin, using permethrin‐impregnated bed netting, insect screens over open windows, when possible staying in air‐conditioned rooms, using aerosol insecticide indoors and pyrethroid coils outdoors and inspecting for ticks. Exposure to sexually transmitted diseases, hepatitis B and C and HIV can occur with unprotected sexual activity, tattooing and body piercing, the administration of blood products, and dental and surgical procedures.9 Visitors (eg, veterinarians) to countries with elevated rabies risk should receive the vaccine and those who are bitten or scratched should be advised to immediately seek medical help and postexposure immunization and immunoglobulin.10

Travelers should be clearly warned that unsafe pedestrian activities in developing countries carry a high risk of injury. Night travel should be avoided and when traveling by motorized vehicle seat belts should be used (car seat with infants and small children). Alcohol should be used with discretion and only in a controlled environment. It accelerates dehydration on an airplane. Lastly, a clear understanding of local crime risks is essential.11 This should include scam awareness, situational awareness, and location avoidance.12

4. Preventive Care

Table 3 lists the vaccines commonly indicated for a traveler.13, 14, 15 Ideally, there should be sufficient time to provide the necessary vaccines so that their efficacy is maximized. Individuals with liver disease such as cirrhosis should receive all hepatitis vaccinations.9 Special consideration should be given for rabies vaccine if the traveler is planning to a prolonged visit or work in an indigenous area.10 Live virus vaccines (eg, measles, mumps, rubella, and varicella) are generally contraindicated in the pregnant female, or one who may conceive while traveling.16

Table 3

Vaccines commonly indicated for a traveler

However, risk and benefit need to be examined in some individual cases. Contraception for 2 months after the vaccination of live viruses should be advised. Yellow fever vaccination may be considered after the 6th month of pregnancy, when the risk of exposure is deemed greater than the risk to the fetus. Pregnant women should be advised not to travel to areas where there is a risk of exposure to yellow fever.17

Chemoprophylaxis and self‐care medications are listed in Table 4. These include medications for malaria, diarrheal illnesses, high altitude, and motion sickness.18, 19, 20, 21, 22, 23 The patient should be instructed on the appropriate use of these medications and when to seek help should illness occur. Mefloquine has been known to exacerbate depression.24, 25 Scopolamine can lead to dysuria or urinary obstruction in male travelers with benign prostatic hypertrophy.26

Table 4

Travel Medications: Prophylaxis and Self‐Care

A travel emergency kit can also be discussed with the patients. Content suggestions include a copy of medical records and extra pair of glasses, prescription medications, over‐the counter medicines and supplies (eg, analgesics, decongestant, cold medicine, cough suppressant, antibiotic/antifungal/hydrocortisone creams, antacids), gauze bandages, tape, self‐adhering elastic bandages, moleskin, insect repellant, sunscreen, lip balm, tweezers, scissors, and a thermometer.27

5. Healthcare Information Resources

There are a number of reliable sources available for healthcare professionals and travelers.28 A number of them provide regular updates, travel notices and warnings based on infectious outbreaks, environmental dangers, or political unrest. A recommended list is provided in Table 5. A number of textbooks and journals are also available if more detailed information is required (Table 6).

Table 5

Recommended list of healthcare information resources in travel medicine

Table 6

Major journals and textbooks for travel medicine

Conflict of Interest

The authors have stated explicitly that there are no conflicts of interest in connection with this article.

Notes

Kamata K, Birrer RB, Tokuda Y. Travel medicine: Part 1–The basics. J Gen Fam Med. 2017;18:52–55. https://doi.org/10.1002/jgf2.39

References

1. Heywood AE, Watkins RE, Iamsirithaworn S, Nilvarangkul K, MacIntyre CR. A cross‐sectional study of pre‐travel health‐seeking practices among travelers departing Sydney and Bangkok airports. BMC Public Health. 2012;12:321. [PubMed]
2. UNWTO . Tourism highlights. 2015 Edition 2014 [cited 2015 Dec 23]. Available from http://www.e-unwto.org/doi/pdf/10.18111/9789284416899
3. McIntosh IB. The pre‐travel health consultation. J Travel Med. 2015;22:143–4. [PubMed]
4. Steffen R, Rickenbach M, Wilhelm U, Helminger A, Schar M. Health problems after travel to developing countries. J Infect Dis. 1987;156:84–91. [PubMed]
5. Steffen R, Amitirigala I, Mutsch M. Health risks among travelers–need for regular updates. J Travel Med. 2008;15:145–6. [PubMed]
6. Hargarten SW, Baker TD, Guptill K. Overseas fatalities of United States citizen travelers: an analysis of deaths related to international travel. Ann Emerg Med. 1991;20:622–6. [PubMed]
7. Wieten RW, Leenstra T, Goorhuis A, van Vugt M, Grobusch MP. Health risks of travelers with medical conditions—a retrospective analysis. J Travel Med. 2012;19:104–10. [PubMed]
8. Gately R, Economos H, Fleming C, Flaherty G. Obtaining a reliable travel history from III returned travellers. Travel Med Infect Dis. 2015;5:3–13. [PubMed]
9. Keeffe EB. Hepatitis A and B superimposed on chronic liver disease: vaccine‐preventable diseases. Trans Am Clin Climatol Assoc. 2006;117:227–37. discussion 37‐8. [PubMed]
10. Gautret P, Parola P. Rabies vaccination for international travelers. Vaccine. 2012;30:126–33. [PubMed]
11. Han P, Balaban V, Marano C. Travel characteristics and risk‐taking attitudes in youths traveling to nonindustrialized countries. J Travel Med. 2010;17:316–21. [PubMed]
12. Leggat PA, Franklin R. Risk perception and travelers. J Travel Med. 2013;20:1–2. [PubMed]
13. CDC U . Vaccines to update or consider during pre‐travel consultations, Travelers’ Health 2015. [cited 2015 Dec 23]. Available from http://wwwnc.cdc.gov/travel/yellowbook/2016/the-pre-travel-consultation/the-pre-travel-consultation#4507
14. Ericsson CD, Zuckerman JN, Connor BA, von Sonnenburg F. Hepatitis A and B booster recommendations: implications for travelers. Clin Infect Dis. 2005;41:1020–6. [PubMed]
15. LaRocque RC, Deshpande BR, Rao SR, et al. Pre‐travel health care of immigrants returning home to visit friends and relatives. Am J Trop Med Hyg. 2013;88:376–80. [PubMed]
16. Sur DK, Wallis DH, O'Connell TX. Vaccinations in pregnancy. Am Fam Physician. 2003;68:299–304. [PubMed]
17. Staples JE, Gershman M, Fischer M. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59:1–27. [PubMed]
18. Travel C, Medicine CtAoT . 2004 Canadian recommendations for the prevention and treatment of malaria among international travellers. Can Commun Dis Rep. 2004;2004:1. [PubMed]
19. Høgh B, Clarke PD, Camus D, et al. Atovaquone‐proguanil versus chloroquine‐proguanil for malaria prophylaxis in non‐immune travellers: a randomised, double‐blind study. Lancet. 2000;356:1888–94. [PubMed]
20. Leshem E, Meltzer E, Stienlauf S, Kopel E, Schwartz E. Effectiveness of short prophylactic course of atovaquone‐proguanil in travelers to sub‐Saharan Africa. J Travel Med. 2014;21:82–5. [PubMed]
21. Jelinek T. Artemisinin based combination therapy in travel medicine. Travel Med Infect Dis. 2013;11:23–8. [PubMed]
22. Westercamp N, Arguin PM. Malaria chemoprophylaxis: a proven public health intervention for international travelers. Travel Med Infect Dis. 2015;13:8. [PubMed]
23. Van Genderen P, Van Thiel P, Mulder P, Overbosch D. Trends in the knowledge, attitudes and practices of travel risk groups towards prevention of malaria: results from the Dutch Schiphol Airport Survey 2002 to 2009. Malar J. 2012;11:179. [PubMed]
24. Nosten F, van Vugt M. Neuropsychiatric adverse effects of mefloquine. CNS Drugs. 1999;11:1–8.
25. Weinke T, Trautmann M, Held T, et al. Neuropsychiatric side effects after the use of mefloquine. Am J Trop Med Hyg. 1991;45:86–91. [PubMed]
26. Hain TC, Yacovino D. Pharmacologic treatment of persons with dizziness. Neurol Clin. 2005;23:831–53. [PubMed]
27. Rodriguez‐Morales AJ, Schlagenhauf P. Zoonoses and travel medicine:”one world–one health”. Travel Med Infect Dis. 2014;6:555–6. [PubMed]
28. Chiodini J, Anderson E, Driver C, et al. Recommendations for the practice of travel medicine. Travel Med Infect Dis. 2012;10:109–28. [PubMed]

Articles from Journal of General and Family Medicine are provided here courtesy of Wiley-Blackwell